Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.

Abstract

To our knowledge, our data provide the first comprehensive clinical evidence that FOXA2, FOXN2, FOXN3 and FOXG1 are promising biomarkers of GBM and warrant further investigation.